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Abstract
The major obstacle of successful tumor treatment with carboplatin (CBP) is the development of drug resistance. In the
present study, we found that following treatment with CBP the amount of platinum which enters the human laryngeal
carcinoma (HEp2)-derived CBP-resistant (7T) cells is reduced relative to the parental HEp2. As a consequence, the formation
of reactive oxidative species (ROS) is reduced, the induction of endoplasmic reticulum (ER) stress is diminished, the amount
of inter- and intrastrand cross-links is lower, and the induction of apoptosis is depressed. In HEp2 cells, ROS scavenger
tempol, inhibitor of ER stress salubrinal, as well as gene silencing of ER stress marker CCAAT/enhancer-binding protein
(CHOP) increases their survival and renders them as resistant to CBP as 7T cell subline but did not influence the survival of
7T cells. Our results suggest that in HEp2 cells CBP-induced ROS is a stimulus for ER stress. To the contrary, despite the
ability of CBP to induce formation of ROS and activate ER stress in 7T cells, the cell death mechanism in 7T cells is
independent of ROS induction and activation of ER stress. The novel signaling pathway of CBP-driven toxicity that was
found in the HEp2 cell line, i.e. increased ROS formation and induction of ER stress, may be predictive for therapeutic
response of epithelial cancer cells to CBP-based therapy.
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Introduction
Carboplatin (cis-Diammine(1,1-cyclobutanedicarboxylato)plati-
num(II); CBP) is an important drug used to treat different types of
epithelial tumors [1,2,3]. Although, CBP is effective in many
cancers, its long-term clinical usage has been limited because of
the development of tumor drug resistance [4,5,6]. Establishment of
epithelial tumor cell lines resistant to clinically relevant doses of
CBP is a useful approach in the identification of potential
molecular targets in order to overcome drug resistance, and these
biomarkers may be useful in predicting CBP sensitivity or
resistance. Several molecular mechanisms have been described
to be involved in CBP resistance: (a) diminished drug accumula-
tion, (b) elevated drug inactivation, (c) DNA repair or elevated
DNA damage tolerance, (d) enhanced expression of anti-apoptotic
genes, and (e) inactivation of the p53 pathway (all reviewed in
[5,7]). However, none of these molecular mechanisms was found
to be the single dominant factor determining CBP resistance.
More likely, CBP resistance is a result of multiple mechanisms
activated in parallel upon drug treatment.
Although only a small percentage of cell-associated CBP is
found in the DNA fraction [8], it is generally accepted that DNA
damage is a main cause of platinum-induced cell death
[5,9,10,11,12]. However, there is evidence showing that CBP
can also induce oxidative stress [13]. Carboplatin causes reactive
oxidative species (ROS) formation, depletes the cellular pool of
antioxidants, and causes oxidative injury in the cochleae of rats
[14], specifically in the interior collicolus, leading to hearing loss
[15]. The overexpression and activation of the heme oxygenase
(HO)-1, which is an inducible form of HO in response to oxidative
stress, provided protection against CBP-induced injury [16].
Reactive oxidative species can induce the endoplasmic reticu-
lum (ER) stress response [17], a consequence of the accumulation
of unfolded and/or misfolded proteins in the ER lumen. Different
types of cellular stresses such as nutrient deprivation, disturbance
of calcium flux or alterations in the glycosylation status can cause
ER stress. ER stress further triggers signaling pathways which
promote cell death [18]. Cisplatin (cDDP), the parent compound
of CBP, has been shown to cause ER stress and DNA damage-
independent cell death [19,20]. Further, in renal tubular epithelial
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cells caspase-12, a marker of ER stress, plays a pivotal role in
cDDP-induced cell death [21].
We hypothesized that CBP-induced ROS is one of the triggers
of ER stress. To support this hypothesis, ROS formation and the
induction of ER stress were comparatively investigated in human
laryngeal carcinoma parental HEp2 cells and their CBP-resistant
7T subline following treatment with CBP. Additionally, we
examined the influence of ROS scavenger tempol, specific
inhibition of ER stress by salubrinal and RNAi mediated
downregulation of one of the marker of ER stress on cellular
sensitivity to CBP.
Materials and Methods
Cell lines
Human laryngeal carcinoma (HEp2) cells were obtained from a
cell culture bank (GIBCO/BRL Life Technologies, Germany;
ATCC Nr. CCL-23) and their authenticity was confirmed by
Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganis-
men und Zellkulturen GmbH. A human laryngeal carcinoma cell
subline resistant to carboplatin (7T) was selected by CBP (Sigma-
Aldrich, Germany; Cat. Nr. C2538) treatment of parental HEp2
cells [22]. Briefly, the cells were treated continuously with CBP for
five consecutive days, and cultured in drug-free medium until
surviving cells recovered and achieved a normal growth rate.
Thereafter, they were treated again for five days with increased
concentrations of CBP. These five-day cycles were repeated until
the clinical relevant concentration of 9 mg/L (24 mM) of CBP was
reached. The 7T subline was then isolated from the CBP-resistant
cell population [22]. Both cell lines were grown in Dulbecco’s
medium (Gibco BRL Life Technologies; Cat. Nr. 11965) supple-
mented with 10% fetal bovine serum (Sigma-Aldrich; Cat.
Nr. F7524) and cultured in a humidified atmosphere of 5%
CO2 at 37uC.
Determination of cell survival
The sensitivity of HEp2 and 7T cells upon CBP treatment was
determined using the MTT colorimetric assay [23] (Sigma-
Aldrich; Cat. Nr. M2128). Briefly, cells were seeded in 96-well
tissue culture plate (2.56103 cells/well) and allowed to attach
overnight, followed by, if indicated, two hours pretreatment with
tempol or salubrinal (Santa Cruz Biotechnology; Cat. Nr. sc-
200825, Cat. Nr. sc-202332) and/or only treatment with different
concentrations of CBP. Following 72 h drug incubation, the MTT
reagent was added, the resulting MTT-formazan product was
dissolved in DMSO and absorbance measured using a microplate
reader (Awareness Technology Inc., USA) at 545 nm.
Determination of apoptosis
Apoptosis was determined using fluorescence microscopy.
Untreated and treated cells were trypsinized, harvested, and
collected by centrifugation. The cells were resuspended in a
Dulbecco’s medium at a cell density of 16106 cells/mL and
stained by mixing 10 mL of a cell suspension with 4 mL of 1%
propidium iodide (Sigma-Aldrich; Cat. Nr. P4170) and 2 mL of
1% ethidium bromide (Sigma-Aldrich; Cat. Nr. E8751). Apoptotic
cells with characteristic morphology were identified under a
fluorescence microscope. At least 300 cells were counted per
sample. The percentage of apoptotic cells was calculated relative
to the number of viable and necrotic cells.
Preparation of total cell extracts
The cells were trypsinized and harvested by centrifugation,
washed with PBS and resuspended in sonication buffer (20 mM
Tris/HCl, pH 8.5, 1 mM EDTA, 5% glycerin, 1 mM DTT,
0.5 mM PMSF). After sonication, cell debris was removed by
centrifugation (15 min, 20,0006 g at 4uC). The supernatants
containing total cellular proteins were collected and protein
concentration was determined.
Western blot analysis
30 mg of total cellular proteins were loaded onto a 10% SDS
polyacrylamide gel and run for 2 h at 35 mA. Separated proteins
were transferred onto a 0.2 mm nitrocellulose membrane (Schlei-
cher and Schu¨ll, Germany; Cat. Nr. NBA083C001EA) in a Bio-
Rad blot cell (Bio-Rad, USA) using buffer consisting of 25 mM
Tris/HCl, 86 mM glycine and 20% methanol. To avoid
nonspecific binding, the membrane was incubated in blocking
buffer (5% nonfat dry milk, 0.1% Tween 20 in PBS) for one hour
at room temperature. Incubation with monoclonal and phosphor-
polyclonal antibodies was performed overnight at 4uC. The
incubation with polyclonal antibodies was performed for two
hours at room temperature. Following primary antibodies were
used: activating transcription factor 4 (ATF4), eukaryotic initiation
factor 2 alpha (eIF2a), X-box binding protein 1 (XBP-1) (Santa
Cruz Biotechnology; Cat. Nr. sc-200, Cat. Nr. sc-30882, Cat.
Nr. sc-7160), p-histone H2AX (EMD Millipore, USA; Cat.
Nr. 05-636), CCAAT/-enhancer-binding protein homologous
protein (CHOP), glucose-regulated protein (Grp78), phospho-
eIF2a (p-eIF2a; Cell Signaling Technology, USA; Cat. Nr. 2895,
Cat. Nr. 3177, Cat. Nr. 9721). After washing with 0.01% Tween-
20 in PBS and incubation with corresponding horseradish-
peroxidase-coupled secondary antibody (Amersham Pharmacia
Biotech, Germany; Cat. Nr. NA931 and Cat. Nr. NA934 and
Santa Cruz Biotechnology; Cat. Nr. sc-2020), proteins were
visualized with ECL (Amersham Pharmacia Biotech; Cat.
Nr. RPN2106) according to the manufacturer’s protocol. All
membranes were incubated with anti-extracellular-signal-regulat-
ed kinases 1/2 or 2 (anti-ERK1/2 or anti-ERK2) (Santa Cruz
Biotechnology, USA; Cat. Nr. sc-153, Cat. Nr. sc-292838) anti-
body to confirm equal protein loading. ERK2 or ERK1/2 were
used as loading controls since no changes in total ERK1 and
ERK2 expression was detected upon exposure of cells to different
drugs [24,25].
South-western slot-blot analysis
Genomic DNA was isolated from sub-confluent cells by use of
the QIA(amp) blood mini kit (Qiagen, Germany). 1 mg DNA was
transferred to a positively charged nylon membrane (Hybond plus,
Amersham Pharmacia Biotech; Cat. Nr. RPN203B) by vacuum
slot-blotting, denatured with 0.3 M NaOH, neutralized with 56
SSC, and fixed by baking the membrane for 2 h at 80uC. Equal
DNA loading was ensured by measurement of DNA concentration
and by densitometrical determination of DNA concentration on
agarose gel prior to spotting. Furthermore, equal DNA loading on
the nylon membrane upon chemiluminescence was confirmed by
staining the membrane in an aqueous solution of 0.5 mg/mL
ethidium bromide for about 30 min. Upon staining, the
membrane was rinsed in water for 15 min and the integrated
ethidium bromide was visualized by a transilluminator, photo-
graphed and the spots compared by densitometry. The antibody
specifically detecting 1,2-GG intrastrand cross-links induced by
CBP was kindly provided by J. Thomale (Essen, Germany) and
was described elsewhere [26]. The western blot procedure was
performed as described above.
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Isolation of RNA, semi-quantitative and real-time PCR
RNA was isolated from sub-confluent growing cells with the use
of High Pure RNA Isolation Kit (Roche, Germany; Cat.
Nr. 11828665001) and 1 mg RNA was used for first-strand cDNA
synthesis by using the RevertAid First Strand cDNA Synthesis Kit
(Thermo Scientific, USA; Cat. Nr. K1622) according to the
manufacturer’s protocols. Serial two-fold dilutions of cDNA were
prepared and amplified by PCR in order to ensure analysis in the
exponential phase of the PCR reaction. Initial denaturation for all
PCR reactions was 2.5 min at 95uC. Initial dilutions of cDNA for
each reaction, primer sequences and conditions used for PCR
amplifications are given in Table 1. The PCR products obtained
by primers specific for rps18 were used as loading controls. All
PCR products were resolved by electrophoresis on 1.2% agarose
gels, stained with ethidium bromide and visualized under
ultraviolet light. The intensity of each band was determined by
densitometry. For detection of Grp78 and CHOP mRNA
expression Real-Time PCR was used. Real-Time PCR analysis
was performed in triplicate on the QuantStudio 12K Flex Real-
Time PCR System (Life Technologies) using the SYBR Green
PCR Master mix (Life Technologies; Cat. Nr. 4309155). The
PCR conditions were as follows: one cycle at 95uC for 10 min
followed by 40 cycles at 95uC for 15 sec and at 60uC for 1 min.
After amplification, dissociation curves were performed to ensure
that a single PCR product had been amplified. For Grp78, the
forward primer was 59-GTTCTTGCCGTTCAAGGTGG-39 and
reverse was 59-TGGTACAGTAACAACTGCATG-39. For
CHOP, the forward primer was 59-ATGAGGACCTGCAA-
GAGGTCC-39 and the reverse was 59-TCCTCCTCAGT-
CAGCCAAGC-39. For GAPDH, the forward primer was 59-
TGCACCACCACTGCTTAGC-39 and the reverse was 59-
GGCATGGACTGTGGTCATGAG-39. All the reactions were
performed in triplicate, and the QuantStudio 12K Flex Software
v1.0 was used for the quantification of the expression for each
segment. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
was used as a normalization control gene.
Determination of reactive oxidative species
Generation of ROS was determined using the fluorescent dye
5-(and-6)-chloromethyl-29,79-dichlorodihydrofluorescein diacetate,
acetyl ester (CM-H2DCFDA) (Life Technologies; Cat. Nr. C6827).
Briefly, logarithmically growing cells were incubated with 10 mM
CM-H2DCFDA for 1 h according to manufacturer’s instructions.
Afterward, the medium with dye was removed and cells were
incubated in fresh medium with 40 mg/mL CBP for the indicated
time periods. After trypsinization and centrifugation, cells were fixed
in cold 80% methanol. Shortly before measurement, cells were
centrifuged and resuspended in PBS. The fluorescence of the
product, which is formed upon removal of the acetate groups from
CM-H2DCFDA by ROS, was measured by flow cytometry.
Incubation of cells with 0.1% H2O2 for 30 min was used as the
positive control.
Determination of DNA platination and total cell
platination
To investigate the DNA platination level in parental HEp2 cells
and HEp2-derived CBP-resistant 7T subline, cells were treated
with different concentrations of CBP for various periods of time.
The cells were harvested and DNA was isolated using QIAamp
DNA Blood Mini (Qiagen, USA; Cat. Nr. 51104) according to the
manufacturer’s protocol. The concentration of isolated DNA was
measured with Shimadzu-BiospecNano (Shimadzu Biotech, Ger-
many) and the amount of platinum (Pt) atoms bound to DNA was
measured by a validated high resolution inductively coupled
plasma mass spectrometry (HR ICPMS) using the Element 2
(Thermo Finnigan, Bremen, Germany). The platinum nucleotide
content was calculated using the relative molar masses of platinum
and nucleotides obtained from DNA concentration [27]. Calibra-
tion standards were prepared from platinum standard solution
1 g/L in 2 M HCl (Fluka Riedel-de Hae¨n, Germany; Cat.
Nr. 80964). Total cell platination was measured as described
previously [28]. Briefly, the cells were rinsed with ice-cold PBS,
and harvested into 10 ml of ice-cold PBS using a rubber
policeman. After centrifugation, the cells were resuspended in
PBS, an aliquot was used for determination of cell number, and
the remainder was digested in 70% nitric acid. Cell lysates were
heated for 2 h at 75uC, diluted to 5% nitric acid, and assayed for
platinum content.
Gene silencing
For silencing of CHOP gene, the predesigned 100 nM of
CHOP-specific siRNA (Silencer Select Predesigned siRNA;
Ambion, USA; locus ID 1649) and control nonspecific siRNA
for human (Silencer Select Predesigned siRNA Negative Control
#1 siRNA; Ambion) were used. The transfection of siRNA was
performed using Lipofectamine RNAiMAX Reagent (Life Tech-
Table 1. Primer sequences and conditions used for PCR amplification.
Gene Sequence (59 to 39) Denaturation Annealing Extension Cycle cDNA
no. dilution
ctr1 F taagattcggagagagaggtgc 30 s at 95uC 30 s at 63uC 30 s at 72uC 25 4-fold
R aggctctctcggggctatctt
nhe 1 F ccagtcattgccttctacc 30 s at 95uC 45 s at 63uC 60 s at 72uC 30 4-fold
R tgtgtctgttgtaggaccgc
atp7a F cagttcaagacaaggaggaagg 30 s at 95uC 45 s at 63uC 60 s at 72uC 30 8-fold
R tgtgctttgttggttgccagg
mrp2 F gaacaattgtagagaaaggatc 40 s at 95uC 40 s at 52uC 90 s at 72uC 31 8-fold
R cacaaacgcaaggatgatgaagaa
rps18 F gtgtgctggcctcggacacg 45 s at 95uC 30 s at 61uC 30 s at 72uC 29 20-fold
R caacatcgatgggcggcgga
doi:10.1371/journal.pone.0076397.t001
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nologies; Cat. Nr. 13778) according to the manufacturer’s
instructions in parental HEp2 and CBP-resistant 7T cells. 48 h
after transfection the transfected cells were tested for CHOP
expression by western blot and plated for assessment of cell
survival by MTT assay or cell death by fluorescein diacetate and
propidium iodide staining.
Statistical analysis
All data were analyzed by unpaired Student’s t-test and
expressed as the mean 6standard error of the mean. Data were
considered significant when P,0.05. All experiments were
performed in triplicate and repeated at least two times.
Results
CBP-induced apoptosis is reduced in CBP-resistant 7T
cells
The 7T cell subline resistant to CBP was developed from HEp2
cells by stepwise exposure to CBP [22]. In order to determine the
type of CBP-induced cell death, logarithmically growing HEp2
and 7T cells were treated continuously for 72 h with 9, 20 and
40 mg/mL of CBP or with 40 mg/mL CBP for 24, 48 and 72 h. In
dose- and time-course experiments a reduced frequency of
apoptotic cells following CBP treatment was observed in 7T cells
as compared to parental HEp2 cell line (Fig. 1A). Furthermore,
apoptotic cells in sensitive HEp2 cells were visible following the
24 h incubation, but not in 7T cells. The proportions of necrotic
cells were similar in both cell types (data not shown). Thus, CBP
resistance in 7T cells is associated with reduced induction of
apoptosis. Protection of 7T cells from apoptosis following
treatment with CBP was confirmed upon treatment of HEp2
and 7T cells with 40 mg/mL CBP for 24–48 h (Fig. 1A, lower
figure).
Fig. 1B shows that cleavage of PARP in HEp2 cells was
detectable 16 and 24 h after continuous exposure to CBP.
Following a 48 h incubation, PARP protein was only weakly
detectable in HEp2 cells, indicating that the majority of cells
progressed to cell death. By contrast, cleavage of PARP in 7T cells
occurred not before 24 h after the start of CBP treatment.
Notably, PARP protein was still clearly detectable at the 48 h time
point (Fig. 1B). These findings are in agreement with the results
shown in Fig. 1A. Similar results were obtained upon western blot-
based determination of procaspase-3 cleavage. The cleavage of
procaspase-3 in HEp2 cells occurred 16 h after CBP treatment,
and the procaspase-3 protein disappeared completely within 48 h,
demonstrating that HEp2 cells underwent apoptosis. Cleavage of
procaspase-3 in 7T cells was not detectable during the investigated
time course (Fig. 1B). These results demonstrate that continuous
exposure to CBP induces apoptosis in both HEp2 and 7T cells.
Yet, cell death is triggered earlier and with higher efficacy in the
parental HEp2 cells.
Resistant 7T cells reveal reduced CBP accumulation
In Pt-drug resistant cells a reduced intracellular accumulation of
the drug has often been observed [5,6,7]. To determine whether
the increased survival of 7T cells upon CBP treatment was linked
to changes in intracellular Pt content, total cell platination was
measured by ICPMS, following overnight exposure with 40 mg/
mL CBP. The data, normalized to Pt standard, showed a reduced
Pt accumulation in 7T as compared to HEp2 cells (Fig. 2A) and a
lower level of DNA-Pt adducts (,about 6 fold less in 7T versus
HEp2 cells) (Fig. 2B). Therefore, our results show that 7T cells
accumulate less Pt, resulting in a lower level of DNA-Pt adducts as
compared to parental HEp2 cells.
CBP induces less DNA lesions in resistant 7T cells
In order to determine whether the difference in intracellular
accumulation of platinum observed in HEp2 and 7T cells was
detectable at the level of DNA as well, we measured the kinetics of
formation of DNA intrastrand and DNA interstrand cross-links
induced by CBP in HEp2 cells and its CBP-resistant 7T subline.
DNA-Pt adducts were detectable 1.5 h after CBP treatment in
HEp2 cells, whereas a similar content of DNA-Pt adducts in the
7T cell line was attained after a 6 h incubation (Fig. 3A). The
different levels of intrastrand DNA-Pt adducts in parental HEp2
and CBP-resistant 7T cells were detected up to 16 h after CBP
treatment (Fig. 3A). Densitometric analysis at 16 h reveals about
2.3-fold less DNA-Pt adducts in 7T as compared to HEp2 cells. In
order to assess indirectly the formation of interstrand cross-links
we measured the level of phospho-H2AX (cH2AX) expression
Figure 1. Induction of apoptosis in HEp2 and 7T cells following
the CBP treatment. (A) The logarithmically growing cells were treated
either with different doses of CBP during 72 h (upper panel) or with
40 mg/mL CBP for indicated time points (lower panel). Cells were
stained with fluorescein diacetate and propidium iodide and examined
by fluorescence microscopy. (B) Cleavage of PARP and pro-caspase 3 in
HEp2 and 7T cell lines upon 48 h treatment with 40 mg/mL CBP.
Representative data of three independent experiments are presented
(mean 6SD). Control cells were collected 24 h after the beginning of
the treatment. *p,0.05.
doi:10.1371/journal.pone.0076397.g001
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accepted as a surrogate marker of DNA double-strand breaks
formed during the processing of interstrand cross-links [29]. CBP-
induced double-strand breaks were measured in cells treated for 3–
24 h with 40 mg/mL CBP. Increased expression of cH2AX was
detectable 16 and 24 h after CBP treatment in both, HEp2 and
7T cells, but the level of cH2AX was much higher in parental
HEp2 than in CBP-resistant 7T cells. Densitometric analysis at
16 h showed about 4.4-fold lower expression of cH2AX in 7T as
compared to HEp2 cells (Fig. 3B). Identical results were obtained
48 h post drug treatment (data not shown). The reduced level of
cH2AX in 7T cells is probably the result of a lower amount of
interstrand cross-links. These results are in the line with the lower
level of DNA platination observed in 7T cells (see Fig. 2B).
During treatment with CBP, the DNA-Pt adducts can be
repaired by different types of DNA repair systems such as
nucleotide excision repair (NER), base excision repair (BER),
mismatch repair (MMR), and double-strand break repair (DSBR)
[5,30]. Therefore, adaptive changes in the expression of proteins
involved in DNA repair could be involved in acquired resistance to
carboplatin [5,11]. Yet, we detected no differences between
parental HEp2 and resistant 7T cells in the constitutive expression
of Ercc1 and XPF (proteins involved in NER), as well as in the
expression of MutL and MutS (proteins involved in MMR), which
are of relevance for platinum sensitivity [6] (data not shown).
Therefore, the decreased levels of platinum-DNA cross-links are
not likely due to changes in DNA repair, but rather decreased
accumulation of platinum in CBP-resistant cells.
To summarize, decreased whole cell platination was observed in
the CBP-resistant 7T relative to parental HEp2 cells, and this is
associated with a lower amount of DNA intra- and interstrand
cross-links.
Expression of CTR1, NHE1, ATP7A and MRP2 mRNAs is
changed in CBP-resistant cells
Decreases in total cell and DNA platination in 7T cells might be
the result of an altered expression of drug transporter proteins/
pumps located in the cell’s or organelles’ membranes [5,6,7,31].
Therefore, mRNA expression of platin influx pumps, namely the
copper transporter (CTR1) and the Na(+)/H(+) exchanger isoform
1 (NHE1), as well as of efflux pumps, such as the copper-
transporting P-type adenosine triphosphatase (ATP7) and the
multidrug resistance associated proteins 1 (MRP2), were measured.
Fig. 4A shows that the mRNA expression of the influx pumps
CTR1 and NHE1 was reduced by 50% and 30%, respectively, in
CBP-resistant 7T as compared to parental HEp2 cells. The
expression of the efflux pumps ATP7A and MRP2 was slightly
increased in 7T as compared to parental HEp2 cells (Fig. 4B).
Thus, the reduced DNA platination of CBP-resistant 7T cells very
likely results from altered expression of transporter proteins.
CBP treatment generates less ROS in resistant 7T cells
Generation of ROS has been demonstrated to be an early event
that triggers apoptosis [32,33]. As shown in Fig. 5A, exposure of
HEp2 and 7T cells to 40 mg/mL CBP resulted in a time-
dependent increase of ROS formation compared with DMSO-
treated controls. ROS formation was significantly increased as
early as 1.5 h after treatment with CBP in parental HEp2 cells,
while the CBP-mediated increase in ROS formation in CBP-
resistant 7T cells was first detected 6 h after CBP treatment. These
results suggest that CBP causes ROS formation very early after
treatment in HEp2 cells and that the generation of ROS is
diminished in the HEp2-derived CBP-resistant 7T cell subline,
probably due to decreased accumulation of platinum in 7T cells.
In order to assess the role of ROS formation in the response of
HEp2 and 7T cells to CBP we used ROS scavenger tempol.
Pretreatment of cells with 0.1 mM of tempol, followed by CBP
treatment resulted in an increased cell survival of HEp2 cells,
showing the importance of ROS generation in CBP-induced cell
death. However, tempol did not have such an effect in 7T cells
which implies that, although triggered, ROS formation is not
involved in response of 7T cells to CBP (Fig. 5B). A similar result
was obtained with another ROS scavenger, N-acetylcysteine (data
not shown).
CBP induced less ER stress in CBP-resistant cells
High amounts of ROS can cause damage to proteins leading to
the so-called unfolded protein/ER stress response [34]. Since
ROS was detected very early upon CBP treatment in HEp2 cells
(observed as early as 1.5 h after CBP treatment), we hypothesize
that CBP-induced ROS could trigger ER stress. To investigate the
possible role of ER stress in response to CBP treatment of HEp2
and 7T cells we pretreated both cell lines with a specific inhibitor
of ER stress, salubrinal. In HEp2 cells salubrinal increased the
survival following the treatment with CBP to the levels of the CBP-
resistant 7T subline (Fig. 6A) indicating the involvement of ER
stress in CBP response, as well as its role in mediating sensitivity to
CBP. However, pretreatment with salubrinal did not have any
Figure 2. Total and DNA-platination in HEp2 and 7T cells. (A)
The logarithmically grown cells were treated with 40 mg/mL CBP. The
adherent cell population was collected at the indicated time points and
total cell platination was measured. (B) The logarithmically grown cells
were treated with 40 mg/mL CBP and the adherent cell population was
collected, DNA was isolated, and DNA-platination was measured.
Representative data of three independent experiments are presented
(mean 6SD). *p,0.05.
doi:10.1371/journal.pone.0076397.g002
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effect in 7T cells (Fig. 6A) indicating that in these cells ER stress is
not involved in a CBP response.
To clarify further the role of CBP-triggered ER stress in our
model system we treated cells with either high doses of CBP
(80 mg/mL) or tunicamycin (10 mg/mL) for a short period of time
(4 and 8 hours) and measured the levels of several typical inducible
ER stress marker proteins: ATF4, p-eIFa and XBP-1 [35]. The
idea of using the well-known ER stress inducer tunicamycin is to
assess the ability of induction of ER stress in HEp2 and 7T cells by
the measurement of ER stress marker proteins. As presented in
Fig. 6B, the treatment with 80 mg/mL CBP during 4 and 8 h
resulted in increased expression of ATF4 and p-eIFa in both
HEp2 and 7T cells. However, the induction of these ER stress
markers, especially ATF4, was higher in HEp2 than in 7T cells.
The differences in intensity of ATF4 and p-eIFa expression
between HEp2 and 7T cells are probably a result of different Pt
level in the cells. The potential of ER stress induction was
comparable in both cell lines since 10 mg/mL tunicamycin
treatment for 4 and 8 h similarly upregulated the expression of
ATF4 and p-eIFa. In neither of the cell lines upon CBP or
tunicamycin treatment we detected any differences in the
expression of eIFa and XBP-1 as compared to untreated controls.
Since the most obvious increase of protein expression upon CBP
and tunicamycin treatment was detected at the level of ATF4
protein we decided to analyze differential response of HEp2 and
7T cells to CBP along with tunicamycin as a control treatment, at
a later time, i.e. 16 and 24 hours and upon lower doses of CBP
(40 mg/mL) and tunicamycin (1 mg/mL). Data in Fig. 6C
confirmed the data from Fig. 6B showing that CBP induces
ATF4 more noticeably and somewhat earlier in HEp2 compared
to 7T cells. Concomitantly, ATF4 induction by 1 mg/mL
tunicamycin was slightly higher in HEp2 than in 7T cells (Fig. 6C).
To summarize, although in HEp2 and 7T cell lines the ER
stress can be successfully induced, as shown by the treatment with
tunicamycin, we observed less pronounced upregulation of the ER
stress markers upon the CBP treatment in 7T than in HEp2 cells,
probably as a consequence of the lower intracellular content of
CBP and lesser ROS generation in 7T as compared to HEp2 cells.
However, while salubrinal has a strong effect on HEp2 survival
upon CBP treatment, an effect which is absent in CBP-resistant
cell line 7T, we can conclude that ER stress is involved in the
response to CBP in parental HEp2 cells but not in CBP-resistant
7T cells.
CBP induces Grp78 and CHOP expression at the mRNA
and protein levels
We next analyzed the downstream key proteins of ER stress
response, the ER stress markers CHOP and Grp78. It is known
that in the case of prolonged or severe ER stress, the apoptotic
process is triggered to eliminate damaged cells [36] and that
Grp78 and CHOP expression increase during that event [37].
24 h after CBP treatment HEp2 cells showed an increase in
CHOP expression as compared to 7T cells. We detected slightly
higher levels of Grp78 protein 16 and 24 h after CBP treatment in
HEp2 as compared to 7T cells (Fig. 7A). The increased expression
of CHOP and Grp78 proteins was confirmed at the mRNA level
upon CBP treatment. Our results show that CBP-resistant 7T cells
display similar mRNA expression of Grp78 and CHOP detected
during different times of drug exposure. However, very early upon
CBP exposure (3 and 6 h), Grp78 mRNA expression increased up
to 2–3-fold compared to untreated cells in the parental HEp2 cell
line and then dropped to a constitutive level in later time points.
CHOP mRNA expression increased 3-fold compared to untreated
cells 24 h upon drug treatment in HEp2 cells (Fig. 7B).
CHOP is involved in response of HEp2 cells to carboplatin
Since the protein expression of CHOP was more evident than
Grp78 we decided to silence CHOP in order to examine its role in
Figure 3. DNA lesions induced by CBP in HEp2 and 7T cells. (A) Upon treatment with 40 mg/mL CBP the cells were collected at the indicated
time points and DNA was isolated and transferred on nitrocellulose membrane. After fixation the membrane was incubated with antibody specifically
recognizing 1,2-GG intrastrand cross-links induced by CBP. (B) The logarithmically growing cells were treated during indicated time points with
40 mg/mL CBP. The phosphorylation of H2AX (cH2AX) was investigated by Western blot analysis. Expression of ERK2 was used as an internal loading
control. Representative data of two independent experiments are presented. Control cells were collected 24 h after the beginning of the treatment.
doi:10.1371/journal.pone.0076397.g003
Carboplatin-Induced Endoplasmic Reticulum Stress
PLOS ONE | www.plosone.org 6 September 2013 | Volume 8 | Issue 9 | e76397
sensitivity of HEp2 and 7T cells to CBP. The silencing of CHOP
gene upon transfection of HEp2 and 7T cells with CHOP-specific
siRNA was successful (Fig. 8A). Transfection of HEp2 and 7T cells
with negative control (nc) siRNA did not influence sensitivity to
CBP as compared to non transfected cells (data not shown). Upon
establishment of successful CHOP silencing, the sensitivity of
HEp2 and 7T cells upon CBP treatment was determined using the
MTT assay. Silencing of CHOP in 7T cells did not change
survival of 7T cells. However, silencing of CHOP in HEp2 cells
significantly increased survival, i.e. induced resistance to CBP as
compared to cells transfected with control nc siRNA (Fig. 8B).
These results were confirmed with measurement of the percentage
of apoptotic cell population specifically 48 h upon CBP treatment
(Fig. 8C). The silencing of CHOP in HEp2 cells significantly
decreased the percentage of apoptotic cell population upon CBP
treatment, while this effect was absent in CBP-resistant cells 7T.
Figure 4. mRNA expression of CTR1, NHE1, ATP7A and MRP2 in HEp2 and 7T cells. The logarithmically growing cells were collected and RNA
was isolated. Semi-quantitative RT-PCR and densitometry analysis of bands were performed. As an internal control for equal RNA/cDNA loading, s18
was used. The representative of 3 independently isolated RNAs and independently performed RT-PCRs are presented. (A) influx pumps CTR1and
NHE1, (B) efflux pumps ATP7A and MRP2.
doi:10.1371/journal.pone.0076397.g004
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Overall, obtained results show that CHOP plays a significant role
in response of HEp2 to CBP while such an effect does not exist in
7T cells.
Discussion
Acquired resistance is a major obstacle to successful chemo-
therapy. It is based on multiple molecular alterations that often
cause resistance not only to the drug to which the cells were
exposed, but also to unrelated anti-cancer drugs. In this work we
use as a model 7T cells obtained by multiple exposures of HEp2
cells to CBP that were cross-resistant to cisplatin, transplatin and
mitomycine C, while their sensitivity to doxorubicin, etoposide,
camptothecin, vincristine, paclitaxel and methylmethanesulfonate
did not change as compared to parental cells. Here we show that
CBP-resistant 7T cells display reduced CBP-induced apoptosis as
compared to parental HEp2 cells. Necrotic cell death was not
affected (data not shown). Similar results have been shown in other
cell models, indicating that changes in apoptosis induction
significantly contribute to a CBP-resistant phenotype [38,39].
The intracellular Pt-level, notably DNA platination, can
determine the final outcome of the treatment with platinum drugs
as described previously (for instance [24]). Therefore, to explain
the lower frequency of apoptotic cells upon the CBP treatment in
Figure 5. CBP induced ROS formation in HEp2 and 7T cells. (A) The logarithmically growing cell lines were treated with 40 mg/mL CBP during
the indicated period of time. The cells were collected, stained with CM-H2DCFDA and ROS was measured by flow cytometry. (B) The HEp2 and 7T cells
were pretreated with 0.1 mM tempol. Two hours later different concentrations of CBP were added. The cell survival was determined 72 hours later by
MTT assay. Representative data of three independent experiments are presented (mean 6SD). *p,0.05. Cic-isotype control, Cc-untreated cells, CBP-
carboplatin treated cells, H2O2-hydrogen peroxide treated cells.
doi:10.1371/journal.pone.0076397.g005
Carboplatin-Induced Endoplasmic Reticulum Stress
PLOS ONE | www.plosone.org 8 September 2013 | Volume 8 | Issue 9 | e76397
7T cells, we measured both the total cell and DNA platination in
HEp2 and 7T cells. The level of platinum detected in CBP-
resistant 7T cells was lower at the level of both total cell and DNA
platination compared to parental HEp2 cell line. In accordance,
reduced level of specific 1,2-GG intrastrand cross-links was found
upon CBP treatment in 7T cells. At a later time point, interstrand
cross-links can appear, leading further to the formation of DNA
double-strand breaks [40,41]. In addition to its role in DNA-
damage repair, H2AX is required for DNA fragmentation during
apoptosis and is phosphorylated by various kinases in response to
apoptotic signals [41]. Our results showed that the lower level of
initial DNA platination in 7T cells resulted in a lower level of
intrastrand cross-links and later in a lower level of DNA double-
strand breaks as indicated by a decreased level of cH2AX protein
expression. Previously, we obtained similar results regarding the
induction and repair of platinum-DNA lesions in human cervical
carcinoma cells resistant to cisplatin [24].
Less Pt detected in the CBP-resistant cells could be based on
decreased influx and/or increased efflux of the drug. Alterations in
the expression of different transporter proteins, such as CTR1,
ATP7A, ATP7B, NHE1, and MRP2 as well as changes in cell
membrane structure can influence active and passive transport of
the drug [42]. We detected slightly reduced mRNA level for CTR1
and NHE1 transporter influx pumps and increased expression of
efflux pumps, ATP7A and MRP2 in CBP-resistant 7T cell subline
as compared to HEp2 cell line. Despite the fact that we did not
measure the protein expression of different transporter proteins,
our data suggest that altered transport of CBP, especially an
increased efflux of Pt out of the cells is probably the main
mechanism of resistance to CBP in 7T cells. The relevance of
changes in drug transport for CBP resistance was demonstrated in
murine embryonic fibroblast. Upon deletion of the CTR1 gene
(ctr12/2 MEFs), a 2-fold CBP resistance was detected [43].
Over-expression of ATP7A in ovarian carcinoma 2008 cells
resulted in higher levels of Pt drug accumulation upon treatment
with the platinum drugs cDDP, CBP and oxaliplatin. However,
these ATP7A over-expressing cells are resistant to all three
examined drugs, indicating that the function of ATP7A in cell
response to platinum drugs is not reduction of accumulation but
more likely the binding and sequestration of Pt drugs [44]. Finally,
for the last examined transporter, MRP2 was found to be
overexpressed in human ovarian carcinoma A2780 cells resistant
to CBP [45]. Yet we cannot exclude a possible role of other
transporter proteins in CBP resistance, such as ATP7B [46].
Furthermore, the passive diffusion of Pt drugs through the cell
membrane can be also altered in CBP-resistant cell lines as
compared to parental cells [5]. Our results indicate that several
platinum transporters are differentially expressed in CBP-resistant
7T cells due to exposure to CBP, resulting in lower intracellular
CBP accumulation and decreased cell death relative to parental
HEp2 cells.
Recent data has shown that cisplatin can induce ROS
formation. In our recent review we presented and discussed the
current knowledge on the molecular mechanism of cDDP-induced
ROS formation, the relationship between ROS formation, the
protective roles of GSH and BCL-2 protein, and highlight possible
mechanisms that may lead to cDDP resistance [47]. Moreover, we
demonstrated that ROS formation is triggered early following
exposure to cDDP, and that cDDP resistance is associated with
GSH-dependent elimination of drug-induced generation of ROS
in integrin aVb3-overexpressing HEp2 cells [48]. In accordance,
CBP-induced ROS formation is thought to be responsible for the
oxidative injury in the cochleae of rats [14]. In addition, it is
reported that CBP-induced cardiotoxicity is related to ROS
Figure 6. CBP induced ER stress in HEp2 and 7T cells. (A) HEp2
and 7T cells were pretreated for two hours with 12.5 mM salubrinal, and
then treated with different concentrations of CBP. Seventy-two hours
later cell survival was measured by MTT assay. Representative data of
three independent experiments are presented (mean 6SD). *Signifi-
cantly different from the respective control. * p,0.05. (B) HEp2 and 7T
cells were treated with 80 mg/mL CBP or 10 mg/mL tunicamycin for 4
and 8 h. At indicated time points the cells were collected and the
expression of ATF4, phospho-eIFa (p-eIFa), eIFa and XBP-1 was
determined. (C) HEp2 and 7T cells were treated with 40 mg/mL CBP
or 1 mg/mL tunicamycin during 16 and 24 h. At indicated time points
the cells were collected and the expression of ATF4 was determined.
ERK2 control was used as an internal loading control. Data of one of two
experiments that yielded similar results are presented. Densitometric
analysis data are expressed as a ratio between examined ER markers
and ERK2. Non treated cells were set as 1.0.
doi:10.1371/journal.pone.0076397.g006
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production in mice and could be prevented by using pravastatin,
which protected against oxidative stress [32]. Production of ROS
is involved in CBP-induced damage to murine cochlear hair cells
and spiral ganglion neurons, and can be attenuated by the
antioxidant NAC [49].
In the present study we show the appearance of ROS at 1.5 h
following CBP treatment in HEp2 cells, while it took 6 h before it
was formed in 7T cells. The role of ROS formation in HEp2 and
7T cell response to CBP was examined by pretreatment of cells
with an effective antioxidant tempol. Tempol increased survival of
HEp2 upon CBP treatment as compared to HEp2 cells treated
only with CBP implicating that generation of ROS impacts cell
survival in cell response to CBP. Pretreatment with tempol did not
change survival rate of 7T cells upon CBP treatment at all. It is
important to note that CBP actually induces ROS in CBP-
resistant cells 7T but a little bit later in time than in HEp2 cells,
very likely due to the lower intracellular content of CBP.
Therefore the inability of tempol to modulate cell survival in 7T
cells indicate that formation of ROS is not involved in 7T cells
response to CBP.
Different cytotoxic drugs can induce the generation of ROS
which further triggers the ER stress response [50]. Namely, it was
shown that cisplatin can induce nuclear damage-independent
apoptosis in enucleated mouse kidney proximal tubule TKPTS
cells [20], and in cytoplasts prepared from human melanoma cell
line 224 and colon cancer HCT116 cell lines [19]. These data
suggest that DNA damage-independent cDDP-induced signaling
pathways are stimulated by oxidative stress. In this report we
showed for the first time that CBP is able to induce ER stress. Our
results show that ER stress signaling is triggered immediately as
CBP enters the cell (4–8 h) since in both cell lines, HEp2 and 7T,
we observed an increase in ATF4 and p-eIFa expression after drug
treatment. However, the induction of these ER stress markers,
especially ATF4, was higher in HEp2 than in 7T cells. As a control
for the general ability of ER stress induction in HEp2 and 7T cells
we used tunicamycin. Tunicamycin was able to evidently induce
similar levels of ATF4 and in lesser extent, p-eIFa expression in
Figure 7. CBP induced Grp78 and CHOP expression in HEp2 but not in 7T cells. (A) Twenty-four hours after the seeding, HEp2 and 7T cells
were treated with 40 mg/mL CBP. At indicated time points the cells were collected and the expression of ER stress markers CHOP and Grp78 was
determined. Expression of ERK2 was used as an internal loading control. (B) HEp2 and 7T cells were treated with 40 mg/mL CBP for 3–24 h. At
indicated time points the cells were collected and the mRNA expression of ER stress markers CHOP and Grp78 was determined. Expression of GAPDH
was used as an internal control.
doi:10.1371/journal.pone.0076397.g007
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HEp2 and 7T cell lines. Finally, the importance of ER stress
induction upon CBP was assessed by pretreatment of HEp2 and
7T cells with salubrinal, a specific inhibitor of ER stress [51].
Namely, salubrinal increased survival rate upon CBP treatment in
parental HEp2 cell line only, emphasizing again the involvement
of ER-stress in cell response to CBP in HEp2 but not in CBP-
resistant 7T cells.
The CBP treatment had differential effect on expression of
downstream ER stress markers Grp78 and CHOP in HEp2 and
7T cells. While in HEp2 Grp78 mRNA increased 3 hours upon
CBP treatment, it took 24 hours for CHOP mRNA upregulation.
In CBP-resistant 7T cells no changes in Grp78 and CHOP mRNA
levels were observed. However, the involvement of endoplasmatic
reticulum stress in the response of HEp2 and 7T cells to CBP was
further analyzed by specific silencing of CHOP gene in both cell
lines. Namely, specific silencing of CHOP gene in HEp2 cells
obtained by transfection with CHOP-specific siRNA increased
survival of HEp2 cell line as compared to the HEp2 cells
transfected with control nc siRNA. Similarly as observed upon
tempol and salubrinal pretreatment, CHOP silencing did not have
any effect on 7T cell response to CBP. Therefore, our data in
HEp2 cells confirmed the role of ER stress in CBP toxicity. It
seems that shortly upon entering the cell, CBP simultaneously
causes DNA damages, triggers production of ROS, and activates
ER stress. We showed that despite the well-accepted fact that
DNA damages are important for CBP cell toxicity, ROS
production plays an important role in this toxicity as well.
Moreover, inhibiting the formation of ROS and ER stress
pathway significantly altered the sensitivity of HEp2 cells to
CBP, rendering them as resistant as 7T cells. Therefore we
conclude that in HEp2 cells the ROS formation and ER stress
induction both play an important role in sensitivity to CBP, and
generally could have a role in CBP resistance. Nevertheless,
inhibiting the formation of ROS and ER stress pathway did not
change sensitivity of CBP-resistant 7T cells to CBP indicating that
in these cells CBP toxicity became independent on ROS induction
and of ER stress.
In summary, our results suggest that in HEp2 cells CBP-induced
ROS is a stimulus for ER stress, which together with DNA lesions,
triggers cell death by apoptosis. Contrary, despite the ability of
CBP to induce formation of ROS and activate ER stress in 7T
cells, the cell death mechanism in 7T cells is independent of ROS
induction and activation of ER stress. Our results contribute to the
knowledge about the variety of mechanisms of cell death to
antitumor drugs, especially for drugs such as CBP, which can act
at multiple levels in a cell. In addition, the novel signaling pathway
of CBP-driven toxicity in the HEp2 cell line, i.e. ROS formation
and induction of ER stress may be a potential target for future
modulation of CBP-based therapy of epithelial cancers and it will
be interesting to determinate whether a similar mechanism exists
in vivo.
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Figure 8. CHOP is involved in response of HEp2 cells to CBP. (A)
Parental HEp2 and CBP-resistant 7T cells were transfected with negative
control siRNA (nc siRNA) or with CHOP-specific siRNA (CHOP siRNA) The
expression of CHOP was determined by western blot 48 h after
transfection. ERK2 was used as equal loading control. Representative
blot of two independent experiments that yielded similar results is
presented. (B) HEp2 and 7T cells were seeded for MTT assay 48 h after
transfection with nc siRNA or CHOP siRNA and treated with CBP 24 h
after. MTT assay data are representative of two independently
performed experiments 6S.D. (C) HEp2 and 7T cells were transfected
with nc siRNA or CHOP siRNA, plated and 24 h later treated with 40 mg/
mL CBP for 48 h. Cells were stained with fluorescein diacetate and
propidium iodide and examined by fluorescence microscopy. Repre-
sentative data of three independent experiments are presented (mean
6SD). *p,0.05.
doi:10.1371/journal.pone.0076397.g008
Carboplatin-Induced Endoplasmic Reticulum Stress
PLOS ONE | www.plosone.org 11 September 2013 | Volume 8 | Issue 9 | e76397
References
1. Bhutani M, Pathak AK, Mohan A, Guleria R, Kochupillai V (2006) Small cell
lung cancer: an update on therapeutic aspects. Indian J Chest Dis Allied Sci 48:
49–57.
2. Pectasides D, Pectasides E, Economopoulos T (2007) Systemic therapy in
metastatic or recurrent endometrial cancer. Cancer Treat Rev 33: 177–190.
3. Kubicek GJ, Kimler BF, Wang F, Reddy EK, Girod DA, et al. (2011)
Chemotherapy in head and neck cancer: clinical predictors of tolerance and
outcomes. Am J Clin Oncol 34: 380–384.
4. Siddik ZH (2003) Cisplatin: mode of cytotoxic action and molecular basis of
resistance. Oncogene 22: 7265–7279.
5. Stewart DJ (2007) Mechanisms of resistance to cisplatin and carboplatin. Crit
Rev Oncol Hematol 63: 12–31.
6. Koberle B, Tomicic MT, Usanova S, Kaina B (2010) Cisplatin resistance:
preclinical findings and clinical implications. Biochim Biophys Acta 1806: 172–
182.
7. Wang D, Lippard SJ (2005) Cellular processing of platinum anticancer drugs.
Nat Rev Drug Discov 4: 307–320.
8. Blommaert FA, van Dijk-Knijnenburg HC, Dijt FJ, den Engelse L, Baan RA, et
al. (1995) Formation of DNA adducts by the anticancer drug carboplatin:
different nucleotide sequence preferences in vitro and in cells. Biochemistry 34:
8474–8480.
9. Zwelling LA, Kohn KW (1979) Mechanism of action of cis-dichlorodiammine-
platinum(II). Cancer Treat Rep 63: 1439–1444.
10. Fichtinger-Schepman AM, van Dijk-Knijnenburg HC, van der Velde-Visser
SD, Berends F, Baan RA (1995) Cisplatin- and carboplatin-DNA adducts: is PT-
AG the cytotoxic lesion? Carcinogenesis 16: 2447–2453.
11. Rabik CA, Dolan ME (2007) Molecular mechanisms of resistance and toxicity
associated with platinating agents. Cancer Treat Rev 33: 9–23.
12. Todd RC, Lippard SJ (2009) Inhibition of transcription by platinum antitumor
compounds. Metallomics 1: 280–291.
13. Carozzi VA, Marmiroli P, Cavaletti G (2010) The role of oxidative stress and
anti-oxidant treatment in platinum-induced peripheral neurotoxicity. Curr
Cancer Drug Targets 10: 670–682.
14. Husain K, Whitworth C, Somani SM, Rybak LP (2001) Carboplatin-induced
oxidative stress in rat cochlea. Hear Res 159: 14–22.
15. Husain K, Whitworth C, Hazelrigg S, Rybak L (2003) Carboplatin-induced
oxidative injury in rat inferior colliculus. Int J Toxicol 22: 335–342.
16. Sue YM, Cheng CF, Chou Y, Chang CC, Lee PS, et al. (2011) Ectopic
overexpression of haem oxygenase-1 protects kidneys from carboplatin-mediated
apoptosis. Br J Pharmacol 162: 1716–1730.
17. Gorlach A, Klappa P, Kietzmann T (2006) The endoplasmic reticulum: folding,
calcium homeostasis, signaling, and redox control. Antioxid Redox Signal 8:
1391–1418.
18. Schonthal AH (2012) Targeting endoplasmic reticulum stress for cancer therapy.
Front Biosci (Schol Ed) 4: 412–431.
19. Mandic A, Hansson J, Linder S, Shoshan MC (2003) Cisplatin induces
endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J Biol
Chem 278: 9100–9106.
20. Yu F, Megyesi J, Price PM (2008) Cytoplasmic initiation of cisplatin cytotoxicity.
Am J Physiol Renal Physiol 295: F44–52.
21. Liu H, Baliga R (2005) Endoplasmic reticulum stress-associated caspase 12
mediates cisplatin-induced LLC-PK1 cell apoptosis. J Am Soc Nephrol 16:
1985–1992.
22. Osmak M, Bizjak L, Jernej B, Kapitanovic S (1995) Characterization of
carboplatin-resistant sublines derived from human larynx carcinoma cells. Mutat
Res 347: 141–150.
23. Mickisch G, Fajta S, Keilhauer G, Schlick E, Tschada R, et al. (1990)
Chemosensitivity testing of primary human renal cell carcinoma by a
tetrazolium based microculture assay (MTT). Urol Res 18: 131–136.
24. Brozovic A, Fritz G, Christmann M, Zisowsky J, Jaehde U, et al. (2004) Long-
term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is
attenuated in human carcinoma cells that acquired drug resistance. Int J Cancer
112: 974–985.
25. Herraiz C, Journe F, Abdel-Malek Z, Ghanem G, Jimenez-Cervantes C, et al.
(2011) Signaling from the human melanocortin 1 receptor to ERK1 and ERK2
mitogen-activated protein kinases involves transactivation of cKIT. Mol
Endocrinol 25: 138–156.
26. Liedert B, Pluim D, Schellens J, Thomale J (2006) Adduct-specific monoclonal
antibodies for the measurement of cisplatin-induced DNA lesions in individual
cell nuclei. Nucleic Acids Res 34: e47.
27. Kloft C, Appelius H, Siegert W, Schunack W, Jaehde U (1999) Determination of
platinum complexes in clinical samples by a rapid flameless atomic absorption
spectrometry assay. Ther Drug Monit 21: 631–637.
28. Katano K, Kondo A, Safaei R, Holzer A, Samimi G, et al. (2002) Acquisition of
resistance to cisplatin is accompanied by changes in the cellular pharmacology of
copper. Cancer Res 62: 6559–6565.
29. Mahajan KN, Nick McElhinny SA, Mitchell BS, Ramsden DA (2002)
Association of DNA polymerase mu (pol mu) with Ku and ligase IV: role for
pol mu in end-joining double-strand break repair. Mol Cell Biol 22: 5194–5202.
30. Reed E (2010) DNA damage and repair in translational oncology: an overview.
Clin Cancer Res 16: 4511–4516.
31. Safaei R (2006) Role of copper transporters in the uptake and efflux of platinum
containing drugs. Cancer Lett 234: 34–39.
32. Cheng CF, Juan SH, Chen JJ, Chao YC, Chen HH, et al. (2008) Pravastatin
attenuates carboplatin-induced cardiotoxicity via inhibition of oxidative stress
associated apoptosis. Apoptosis 13: 883–894.
33. Park GB, Kim YS, Lee HK, Song H, Cho DH, et al. (2010) Endoplasmic
reticulum stress-mediated apoptosis of EBV-transformed B cells by cross-linking
of CD70 is dependent upon generation of reactive oxygen species and activation
of p38 MAPK and JNK pathway. J Immunol 185: 7274–7284.
34. Gregersen N, Bross P (2010) Protein misfolding and cellular stress: an overview.
Methods Mol Biol 648: 3–23.
35. Samali A, Fitzgerald U, Deegan S, Gupta S (2010) Methods for monitoring
endoplasmic reticulum stress and the unfolded protein response. Int J Cell Biol
2010: 830307.
36. Gallerne C, Prola A, Lemaire C (2013) Hsp90 inhibition by PU-H71 induces
apoptosis through endoplasmic reticulum stress and mitochondrial pathway in
cancer cells and overcomes the resistance conferred by Bcl-2. Biochim Biophys
Acta 1833: 1356–1366.
37. Hiss DC, Gabriels GA (2009) Implications of endoplasmic reticulum stress, the
unfolded protein response and apoptosis for molecular cancer therapy. Part I:
targeting p53, Mdm2, GADD153/CHOP, GRP78/BiP and heat shock
proteins. Expert Opin Drug Discov 4: 799–821.
38. Di Felice V, Lauricella M, Giuliano M, Emanuele S, Vento R, et al. (1998) The
apoptotic effects of cisplatin and carboplatin in retinoblastoma Y79 cells.
Int J Oncol 13: 225–232.
39. Heffeter P, Jungwirth U, Jakupec M, Hartinger C, Galanski M, et al. (2008)
Resistance against novel anticancer metal compounds: differences and
similarities. Drug Resist Updat 11: 1–16.
40. Brozovic A, Damrot J, Tsaryk R, Helbig L, Nikolova T, et al. (2009) Cisplatin
sensitivity is related to late DNA damage processing and checkpoint control
rather than to the early DNA damage response. Mutat Res 670: 32–41.
41. Roos WP, Kaina B (2012) DNA damage-induced apoptosis: From specific DNA
lesions to the DNA damage response and apoptosis. Cancer Lett.
42. Hall MD, Okabe M, Shen DW, Liang XJ, Gottesman MM (2008) The role of
cellular accumulation in determining sensitivity to platinum-based chemother-
apy. Annu Rev Pharmacol Toxicol 48: 495–535.
43. Holzer AK, Manorek GH, Howell SB (2006) Contribution of the major copper
influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin,
and oxaliplatin. Mol Pharmacol 70: 1390–1394.
44. Samimi G, Safaei R, Katano K, Holzer AK, Rochdi M, et al. (2004) Increased
expression of the copper efflux transporter ATP7A mediates resistance to
cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin Cancer Res
10: 4661–4669.
45. Materna V, Liedert B, Thomale J, Lage H (2005) Protection of platinum-DNA
adduct formation and reversal of cisplatin resistance by anti-MRP2 hammer-
head ribozymes in human cancer cells. Int J Cancer 115: 393–402.
46. Katano K, Safaei R, Samimi G, Holzer A, Rochdi M, et al. (2003) The copper
export pump ATP7B modulates the cellular pharmacology of carboplatin in
ovarian carcinoma cells. Mol Pharmacol 64: 466–473.
47. Brozovic A, Ambriovic-Ristov A, Osmak M (2010) The relationship between
cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance
to cisplatin. Crit Rev Toxicol 40: 347–359.
48. Brozovic A, Majhen D, Roje V, Mikac N, Jakopec S, et al. (2008) alpha(v)beta(3)
Integrin-mediated drug resistance in human laryngeal carcinoma cells is caused
by glutathione-dependent elimination of drug-induced reactive oxidative species.
Mol Pharmacol 74: 298–306.
49. Moon IJ, Kim KR, Chu HS, Kim SH, Chung WH, et al. (2011) N-
acetylcysteine and N-nitroarginine methyl ester attenuate Carboplatin-induced
ototoxicity in dissociated spiral ganglion neuron cultures. Clin Exp Otorhinolar-
yngol 4: 11–17.
50. England K, Driscoll CO, Cotter TG (2006) ROS and protein oxidation in early
stages of cytotoxic drug induced apoptosis. Free Radic Res 40: 1124–1137.
51. Boyce M, Bryant KF, Jousse C, Long K, Harding HP, et al. (2005) A selective
inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science
307: 935–939.
Carboplatin-Induced Endoplasmic Reticulum Stress
PLOS ONE | www.plosone.org 12 September 2013 | Volume 8 | Issue 9 | e76397
